Centessa Pharmaceuticals plc Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CCCC
C4 Therapeutics, Inc. |
$3.75 | $320.64 M | -1.97 | 145 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$10.50 | $1.29 B | -7.16 | 85 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$39.10 | $3.53 B | -11.86 | 290 | $4.01 M |
DSGN
Design Therapeutics, Inc. |
$5.10 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$1.98 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.90 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.48 | $243.38 M | -1.59 | 133 | $0 |
GNFT
Genfit S.A. |
$3.70 | $269.95 M | -8.62 | 169 | $28.57 M |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
HLVX
HilleVax, Inc. |
$1.98 | $673.22 M | -4.1 | 90 | $0 |
IPSC
Century Therapeutics, Inc. |
$0.92 | $244.54 M | -1.32 | 152 | $2.24 M |
IRON
Disc Medicine, Inc. |
$56.65 | $967.11 M | -11.82 | 82 | $0 |
LRMR
Larimar Therapeutics, Inc. |
$3.62 | $611.84 M | -9.99 | 42 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$10.26 | $652.38 M | -6.03 | 28 | $0 |
NAMSW
NewAmsterdam Pharma Company N.V. |
$12.43 | $1.74 B | 0 | 62 | $12.76 M |
NUVL
Nuvalent, Inc. |
$83.78 | $5.11 B | -32.72 | 127 | $0 |
OPT
Opthea Limited |
$4.67 | $214.34 M | -1.04 | 33 | $124,666 |
STRO
Sutro Biopharma, Inc. |
$2.03 | $303.46 M | -1.97 | 302 | $153.73 M |
TARS
Tarsus Pharmaceuticals, Inc. |
$49.12 | $1.22 B | -6.78 | 244 | $17.45 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
TRDA
Entrada Therapeutics, Inc. |
$12.90 | $531.37 M | 22.81 | 177 | $129.01 M |